One in five Americans suffers from a neurological disease.  Epilepsy alone affects four to six million Americans. Many neurological diseases are usually diagnosed in their advanced stages, and treatments tend to be palliative rather than curative, leaving patients debilitated for years. One in three epileptic patients continues to have seizures, which may be fatal or cause serious disability.

New engineering techniques that if coupled to recent discoveries in neuroscience, could dramatically improve patient quality of life.  Potential benefits include reversing or ameliorating a variety of neurological diseases and making earlier diagnosis possible.

CIMIT’s Neurotechnology Program is focused on developing novel approaches to diagnosis and treatment that integrate the expanding field of neuroscience with the rapidly evolving technology of engineering.